Actemra 200mg, a medication known scientifically as tocilizumab, functions as a potent biologic agent primarily utilized for the control of rheumatoid arthritis. This remarkable agent operates by blocking the activity of interleukin-6 (IL-6), a communication protein crucial in the inflammatory process. Additionally, Actemra exhibits promise in the